Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Zinc finger protein 385B (ZNF385B) is a nuclear transcription factor containing zinc finger domains responsible for nucleic acid binding[3][6]. It is involved in intrinsic apoptotic signaling via p53/TP53-mediated pathways, enabling p53 binding activity, and contributes to regulation of apoptosis within cells[2][3][8][1][10]. Expression of ZNF385B is nuclear and varies across tissues, with noted relevance in neurological tissues[7]. Genetic variations in ZNF385B are associated with autism spectrum disorder and may hold further yet-to-be-established disease roles[2]. No direct pharmacologic agents currently target this protein, and its biomedical significance lies chiefly in transcriptional regulation and apoptosis rather than as a direct therapeutic target.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Zinc finger protein 385B (ZNF385B).